Show simple item record

dc.contributor.advisorRoy, Krishnendu
dc.contributor.authorMejias, Joscelyn Claraluz
dc.date.accessioned2020-09-08T12:40:13Z
dc.date.available2020-09-08T12:40:13Z
dc.date.created2019-08
dc.date.issued2019-05-17
dc.date.submittedAugust 2019
dc.identifier.urihttp://hdl.handle.net/1853/63512
dc.description.abstractPulmonary drug delivery is a non-invasive method for targeted delivery of therapeutics for the treatment of respiratory diseases such as asthma, idiopathic pulmonary fibrosis, or cystic fibrosis. Although the lung appears to be an “easy” target for site-specific delivery, there are several physiologic barriers hindering its effectiveness. For particle deposition in respiratory airways, the aerodynamic diameter of particles should fall between 0.5-5 µm, however, alveolar macrophages rapidly clear particles within this geometric range. Additionally, nano-scale particles are required for efficient transport through the pulmonary mucosa and to facilitate efficient endocytosis for intracellularly targeting therapeutics. These design parameters suggest a two-stage system is necessary for efficient therapeutic delivery; a microparticle for aerodynamic properties and a nanoparticle for drug delivery. A nanoparticle-inside-microgel multi-stage formulation could provide efficient, intracellular delivery of nanoparticles to target cells of interest. The microgel carriers are designed for (a) protease-triggered release of drug loaded nanoparticles, (b) avoiding rapid clearance by alveolar macrophages, and (c) appropriate aerodynamic properties, while the nanoparticles are designed to (a) carry small hydrophobic molecules. The overall objective is to test this delivery system by investigating (i) how the microgels and nanoparticles interact with the phagocytic immune cells in vitro (Aim 1) and in vivo (Aim 2) and (ii) how we can recapitulate the vascular pulmonary environment to study these interactions in an in vitro setting (Aim 3).
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherGeorgia Institute of Technology
dc.subjectNano-in-microgel
dc.subjectLung delivery
dc.subjectNanoparticle
dc.subjectMicroparticle
dc.subjectMicrophysiologic lung-on-a-chip
dc.titleNano-in-micro multi-stage particles for pulmonary drug delivery
dc.typeDissertation
dc.description.degreePh.D.
dc.contributor.departmentBiomedical Engineering (Joint GT/Emory Department)
thesis.degree.levelDoctoral
dc.contributor.committeeMemberGarcía, Andrés J.
dc.contributor.committeeMemberPlatt, Manu O.
dc.contributor.committeeMemberKane, Ravi
dc.contributor.committeeMemberTirouvanziam, Rabindra
dc.date.updated2020-09-08T12:40:13Z


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record